DIAGNOSTIC-ACCURACY OF CONVENTIONAL VERSUS SONOGRAPHY-GUIDED FINE-NEEDLE ASPIRATION BIOPSY OF THYROID-NODULES

Citation
D. Danese et al., DIAGNOSTIC-ACCURACY OF CONVENTIONAL VERSUS SONOGRAPHY-GUIDED FINE-NEEDLE ASPIRATION BIOPSY OF THYROID-NODULES, Thyroid, 8(1), 1998, pp. 15-21
Citations number
47
Categorie Soggetti
Endocrynology & Metabolism
Journal title
ISSN journal
10507256
Volume
8
Issue
1
Year of publication
1998
Pages
15 - 21
Database
ISI
SICI code
1050-7256(1998)8:1<15:DOCVSF>2.0.ZU;2-M
Abstract
Fine-needle aspiration biopsy (FNAB) is an accurate, slightly invasive , and safe method for the preoperative diagnosis of thyroid nodules. R ecently, ultrasound guidance has been suggested as a valuable aid to e nhance FNAB diagnostic performance. In this study, we have compared di agnostic accuracy of conventional FNAB (C-FNAB) versus sonography-guid ed FNAB (SG-FNAB) on a large sample population of 9683 patients with t hyroid nodules. Over a 15-year period, 4986 patients were investigated by C-FNAB and 4697 underwent SG-FNAB. A valid cytological diagnosis w as obtained in 85.3% of C-FNAB and in 91.5% of SG-FNAB cases, allowing detection of thyroid cancer in 1.6% and 2.1% of patients, respectivel y. The indeterminate pattern of follicular neoplasia was observed in 2 38 C-FNAB (5%) and in 272 (5.4%) SG-FNAB nodules. Specimens were cytol ogically inadequate in 433 C-FNAB (8.7%), but only in 167 SG-FNAB case s (3.5%). A total of 535 C-FNAB and 540 SG-FNAB nodules underwent surg ery. False-negative results occurred in 7 C-FNAB nodules (2.3%), but o nly in 3 SG-FNAB cases (1%). Sensitivity, specificity, and global diag nostic accuracy of C-FNAB compared with SG-FNAB were 91.8% versus 97.1 %, 68.8% versus 70.9%, and 72.6% versus 75.9%, respectively. Our resul ts, based on a large population of thyroid nodules, demonstrate that S G-FNAB allows a more precise and adequate sampling of thyroid nodular lesions and is associated with a lower rate of false-negatives, thus i mproving global diagnostic accuracy in the preoperative selection of t hyroid cancer.